Skip to content

MGNX

MACROGENICS INC

NASDAQ · Healthcare · Biotechnology · US

$4.14
+0.24%
Ask drillr
0
Insider buys (3m)
1
Insider sells (3m)
-$129.1K
Net value (3m)
-9.9%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 20, 2026Peters Jeffrey Stuart · officer: Senior VP, GC, and SecretarySale31,105$4.15
Aug 18, 2026Bonvini Ezio · officer: Sr VP, Research & CSOM-Exempt40,000$2.60
May 20, 2026STUMP DAVID C · directorM-Exempt3,750$0.00
May 20, 2026O'Brien Federica F. · directorA-Award3,750$0.00
May 20, 2026Jackson Scott Thomas · directorM-Exempt3,750$0.00
May 20, 2026Koenig Scott · directorA-Award3,750$0.00
May 20, 2026Liu Margaret · directorA-Award3,750$0.00
May 20, 2026O'Brien Federica F. · directorM-Exempt3,750$0.00
May 20, 2026HEIDEN WILLIAM K · directorM-Exempt3,750$0.00
May 20, 2026HURWITZ EDWARD · directorA-Award3,750$0.00
May 20, 2026HURWITZ EDWARD · directorA-Award22,000$4.52
May 20, 2026O'Brien Federica F. · directorA-Award22,000$4.52
May 20, 2026STUMP DAVID C · directorA-Award22,000$4.52
May 20, 2026Chhabra Meenu · directorA-Award3,750$0.00
May 20, 2026Jackson Scott Thomas · directorA-Award3,750$0.00
May 20, 2026Chhabra Meenu · directorA-Award22,000$4.52
May 20, 2026STUMP DAVID C · directorA-Award3,750$0.00
May 20, 2026Ferrante Karen Jean · directorA-Award3,750$0.00
May 20, 2026Liu Margaret · directorM-Exempt3,750$0.00
May 20, 2026Ferrante Karen Jean · directorM-Exempt3,750$0.00
May 20, 2026Ferrante Karen Jean · directorA-Award22,000$4.52
May 20, 2026Liu Margaret · directorA-Award22,000$4.52
May 20, 2026SIEGEL JAY PHILIP · directorM-Exempt3,750$0.00
May 20, 2026HEIDEN WILLIAM K · directorA-Award3,750$0.00
May 20, 2026Jackson Scott Thomas · directorA-Award22,000$4.52
May 20, 2026Koenig Scott · directorA-Award22,000$4.52
May 20, 2026Chhabra Meenu · directorM-Exempt3,750$0.00
May 20, 2026HURWITZ EDWARD · directorM-Exempt3,750$0.00
May 20, 2026HEIDEN WILLIAM K · directorA-Award22,000$4.52
Feb 17, 2026Karrels James · officer: SVP and CFOA-Award25,000$0.00
Institutional positioning

13F filings over the trailing two quarters

New 70Increased 60Reduced 61Sold out 25
FilerActionSharesFiled
ARMISTICE CAPITAL, LLCReduced6,012,000May 15, 2026
ARMISTICE CAPITAL, LLCReduced5,006,752Aug 14, 2026
BlackRock, Inc.Increased4,679,229Aug 7, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased2,963,559May 14, 2026
MILLENNIUM MANAGEMENT LLCIncreased2,794,357May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased2,656,010Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position2,653,853May 15, 2026
RENAISSANCE TECHNOLOGIES LLCReduced2,632,750Aug 13, 2026
ACADIAN ASSET MANAGEMENT LLCIncreased2,544,000May 13, 2026
ACADIAN ASSET MANAGEMENT LLCReduced2,542,643Aug 13, 2026
TWO SIGMA INVESTMENTS, LPIncreased2,527,829May 15, 2026
BANK OF AMERICA CORP /DE/Increased2,488,252Aug 14, 2026
TWO SIGMA INVESTMENTS, LPReduced2,465,699Aug 14, 2026
BANK OF AMERICA CORP /DE/Increased2,401,814May 18, 2026
MILLENNIUM MANAGEMENT LLCReduced2,374,296Aug 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 20, 2026